基金经理：廖裕舟
| 最新价:-(-) | 涨跌幅:- | 涨跌额:- | 折溢价率:- | ||
|---|---|---|---|---|---|
| 单位净值:0.7352 | 净值增长率:1.51% | 累计净值:1.1952 | 截止日期:2023/11/28 | ||
| 最新规模:2.44亿元 | 风险等级:高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
申万菱信中证申万医药生物指数A(163118)申购赎回 |
||||||
|---|---|---|---|---|---|---|
| 报告期 | 期初总份额(份) | 期末总份额(份) | 期间总申购份额(份) | 期间总赎回份额(份) | 期间净申赎份额(份) | 净申赎比例 |
| 2023/9/30 | 327,786,000 | 331,604,000 | 23,755,300 | 19,938,200 | 3,817,100 | 1.16% |
| 2023/6/30 | 338,516,000 | 327,786,000 | 52,008,900 | 62,739,000 | -10,730,100 | -3.17% |
| 2023/6/30 | 326,109,000 | 327,786,000 | 22,326,800 | 20,649,100 | 1,677,700 | 0.51% |
| 2023/3/31 | 338,516,000 | 326,109,000 | 29,682,100 | 42,089,800 | -12,407,700 | -3.67% |
| 2022/12/31 | 279,235,000 | 338,516,000 | 197,513,000 | 138,232,000 | 59,281,000 | 21.23% |
| 2022/12/31 | 332,550,000 | 338,516,000 | 48,494,800 | 42,527,900 | 5,966,900 | 1.79% |
| 2022/9/30 | 311,878,000 | 332,550,000 | 51,114,500 | 30,442,500 | 20,672,000 | 6.63% |
| 2022/6/30 | 279,235,000 | 311,878,000 | 97,903,400 | 65,261,200 | 32,642,200 | 11.69% |
| 2022/6/30 | 303,517,000 | 311,878,000 | 37,075,700 | 28,715,000 | 8,360,700 | 2.75% |
| 2022/3/31 | 279,235,000 | 303,517,000 | 60,827,700 | 36,546,200 | 24,281,500 | 8.7% |
| 2021/12/31 | 316,139,000 | 279,235,000 | 210,257,000 | 247,160,000 | -36,903,000 | -11.67% |
| 2021/12/31 | 265,329,000 | 279,235,000 | 40,150,900 | 26,244,300 | 13,906,600 | 5.24% |
| 2021/9/30 | 259,791,000 | 265,329,000 | 57,795,900 | 52,257,700 | 5,538,200 | 2.13% |
| 2021/6/30 | 316,139,000 | 259,791,000 | 112,311,000 | 168,658,000 | -56,347,000 | -17.82% |
| 2021/6/30 | 284,928,000 | 259,791,000 | 24,426,600 | 49,563,800 | -25,137,200 | -8.82% |
| 2021/3/31 | 316,139,000 | 284,928,000 | 87,884,000 | 119,095,000 | -31,211,000 | -9.87% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。